Enanta Pharmaceuticals
ENTA
#7977
Rank
S$0.47 B
Marketcap
S$16.47
Share price
-1.31%
Change (1 day)
60.16%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -S$66 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are S$69.21 Million. In 2025 the company made an earning of -S$82.42 Million, an increase over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$66 Million-19.92%
2025 -S$82.42 Million-34.07%
2024 -S$0.13 Billion-23.87%
2023 -S$0.17 Billion4.39%
2022 -S$0.16 Billion-4.4%
2021 -S$0.17 Billion91.12%
2020 -S$86.09 Million-407.13%
2019 S$28.03 M-78.63%
2018 S$0.13 B117.97%
2017 S$60.18 M-574.65%
2016 -S$12.68 Million-110.83%
2015 S$0.11 B-4.5%
2014 S$0.12 B-638.53%
2013 -S$22.78 Million-137.98%
2012 S$59.94 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.47 B-50,556.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.33 B-30,755.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
S$7.69 B-11,704.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$6.52 B-9,931.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.94 B-25,643.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.36 B-18,739.29%๐Ÿ‡บ๐Ÿ‡ธ USA